Archive for the ‘Personalized Medicine’ Category

Edward Abrahams - What is the Personalized Medicine Coalition?
Edward Abrahams, Ph.D., President of the Personalized Medicine Coalition, sits down with Slone Partners at the 8th Annual Personalized Medicine Conference at Harvard Medical School.

By: SlonePartnersMedia

Read the original here:
Edward Abrahams - What is the Personalized Medicine Coalition? - Video

Edward Abrahams - Who Needs Personalized Medicine Education; Doctors, Patient or Insurers?
Edward Abrahams, Ph.D., President of the Personalized Medicine Coalition, sits down with Slone Partners at the 8th Annual Personalized Medicine Conference at Harvard Medical School.

By: SlonePartnersMedia

Excerpt from:
Edward Abrahams - Who Needs Personalized Medicine Education; Doctors, Patient or Insurers? - Video

Personalized Medicine Used for the Treatment of Lung Cancer - Joshua R. Sonett, MD
This video describes personlized medicine and tells how it is used to treat lung cancer. For more information, visit http://www.columbiathoracic.org or call 212-305-3408

By: ColumbiaSurgery

Read more:
Personalized Medicine Used for the Treatment of Lung Cancer - Joshua R. Sonett, MD - Video

Alexandra Glucksmann Personalized Medicine
This clip is part of the Career Girls ongoing series of career guidance/inspiration videos. See more at http://www.careergirls.org

By: careergirls

See the rest here:
Alexandra Glucksmann Personalized Medicine - Video

Opening of the Penn State Hershey Institute for Personalized Medicine
Opening of the Penn State Hershey Institute for Personalized Medicine View article at lancasteronline.com

By: lancasteronline

Excerpt from:
Opening of the Penn State Hershey Institute for Personalized Medicine - Video

Big Data and Predictive Analytics for Personalized Medicine
entelos.com Tom Paterson, CTO of Entelos, discusses hypothesis management in drug discovery and how to use Entelos biosimulation software for a different take on big data and predictive analytics for personalized medicine. This is part of the webinar Tom presented on December 12, 2012.

By: Entelossolutions

See the rest here:
Big Data and Predictive Analytics for Personalized Medicine - Video

ResearchAarkstore EnterpriseCompanion Diagnostics in Personalized Medicine and Cancer Therapy

By: Anjali Kalan

Read the original:
ResearchAarkstore EnterpriseCompanion Diagnostics in Personalized Medicine and Cancer Therapy - Video

Moffitt: Personalized Medicine Total Cancer Care
Dr. Bill Dalton, Moffitt

By: tbpartnership

See more here:
Moffitt: Personalized Medicine

Eduardo Vilar-Sanchez, MD, PhD: Genomics of Cancer and Personalized Medicine
From:vitaloptionsViews:0 0ratingsTime:13:14More inScience Technology

Read more here:
Eduardo Vilar-Sanchez, MD, PhD: Genomics of Cancer and Personalized Medicine - Video

Future Direction of Molecular and Personalized Medicine in Breast Cancer
Breast cancer research has reached the precipice of a new era in molecular and personalized medicine. Genome sequencing studies are finding cohesive data on driver mutation and possible targets for treatment. Going forward, the challenge facing researchers is translating these findings into clinically meaningful benefits for patients. For more from this discussion, visit http://www.onclive.comFrom:OncLiveTVViews:6 0ratingsTime:06:16More inEducation

Continued here:
Future Direction of Molecular and Personalized Medicine in Breast Cancer - Video

Advocacy in Action ESMO 2012: What Is Personalized Medicine
Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) introduces personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy discussions.From:vitaloptionsViews:0 0ratingsTime:10:11More inNonprofits Activism

Excerpt from:
Advocacy in Action ESMO 2012: What Is Personalized Medicine - Video

Advocacy in Action ESMO 2012: Personalized Medicine and Patient Education
Lorenz Jost (Chair, ESMO Patient Working Group) talks about personalized medicine and the importance of educating patients on the topic. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy discussions.From:vitaloptionsViews:0 0ratingsTime:03:02More inNonprofits Activism

More:
Advocacy in Action ESMO 2012: Personalized Medicine and Patient Education - Video

Advocacy in Action ESMO 2012: Key Policy Issues In Personalized Medicine
Francesco De Lorenzo (European Alliance on Personalized Medicine Manifesto) talks about the key policy issues around personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy discussions.From:vitaloptionsViews:0 0ratingsTime:06:21More inNonprofits Activism

Read more:
Advocacy in Action ESMO 2012: Key Policy Issues In Personalized Medicine - Video

Advocacy in Action ESMO 2012: What Is the Future Of Personalized Cancer Medicine In Europe?
Ian Banks (Chair of the ECCO Patient Advisory Committee) talks about the futire of personalized cancer medicine in Europe. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy discussions.From:vitaloptionsViews:1 0ratingsTime:05:12More inNonprofits Activism

Read more here:
Advocacy in Action ESMO 2012: What Is the Future Of Personalized Cancer Medicine In Europe? - Video

Advocacy in Action ESMO 2012: The Challenges Of Genetic Marker Testing Requirements
Kathy Oliver (International Brain Tumor Alliance), Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the challenges of the genetic marker testing requirements for patients. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy discussions.From:vitaloptionsViews:0 0ratingsTime:08:58More inNonprofits Activism

Read this article:
Advocacy in Action ESMO 2012: The Challenges Of Genetic Marker Testing Requirements - Video

Advocacy in Action ESMO 2012: Personalized Medicine and Pathology
Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy), Selma Schimmel Vital Options International) and Stefania Vallone (Women Against Lung Cancer Europe - WALCE) discuss pathology and personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy discussions.From:vitaloptionsViews:0 0ratingsTime:16:14More inNonprofits Activism

More:
Advocacy in Action ESMO 2012: Personalized Medicine and Pathology - Video

Advocacy in Action ESMO 2012: Advocate Perspectives in Tissue Collection and Research
Selma Schimmel (Vital Options International), Kathy Oliver (International Brain Tumor Alliance), Francesco De Lorenzo (European Alliance on Personalized Medicine Manifesto), Jola-Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss tissue collection in cancer research. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy discussions.From:vitaloptionsViews:0 0ratingsTime:06:50More inNonprofits Activism

Continue reading here:
Advocacy in Action ESMO 2012: Advocate Perspectives in Tissue Collection and Research - Video

Advocacy in Action ESMO 2012: Cancer and the Media
Selma Schimmel (Vital Options International), Kathy Redmond (Cancer World Magazine), Jola-Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the media and cancer reporting. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy discussions.From:vitaloptionsViews:0 0ratingsTime:12:15More inNonprofits Activism

The rest is here:
Advocacy in Action ESMO 2012: Cancer and the Media - Video

OneMedForum SF2012 Panels: Diagnostics and Personalized Medicine
Jennifer Lieb (Founding Partner of HealthFutures) moderates a panel on Diagnostics and Personalized Medicine, featuring Ann F. Hanham (Managing Director of Burrill and Co.), Yves Dubaquie, Ph.D. (Business Development and Licensing of Novartis Molecular Diagnostics) and Melinda Griffith (Senior Vice President of Product Acquisition and Licensing at Clarient).From:OneMedPlaceViews:1 0ratingsTime:38:31More inScience Technology

Here is the original post:
OneMedForum SF2012 Panels: Diagnostics and Personalized Medicine - Video

The Pathology Informatics Roadmap for Implementing Cancer Personalized Medicine- Michael Becich
From:PathinformaticsViews:2 0ratingsTime:41:58More inPeople Blogs

Read the original:
The Pathology Informatics Roadmap for Implementing Cancer Personalized Medicine- Michael Becich - Video

1. Introduction and Overview- Biotechnology: Panacea or Pandora #39;s Box NQ
Given the rapid recent advances in genomics, agriculture, transgenic biology, stem cell research and other related areas of biotechnology and a prediction that these fields will continue to mature and become increasingly more sophisticated, there is an growing need to create an informed and educated student in this area. We believe that a working knowledge of DNA, genetics, and biotechnology has become as fundamental to a basic education as an understanding of the solar system. In addition, biotechnology fields offer students career opportunities which is best recognized early in their academics so that they can make the appropriate choices to be best prepared. The rise of recent controversy and misconceptions about many areas of biotechnology including GMOs in food, vaccines and vaccination, personalized medicine, stem cell research and many other topics creates a growing educational challenge. The introduction of a general education course which concentrates on evidence based knowledge on biotechnology and is developed for a general audience with a large potential enrollment is designed to meet that challenge. In turn our experience shows that such a course serves to recruit new scientists and other participants into the careers in the emerging new fields of biotechnology and stimulates further interest in STEM related disciplines. The courses in this series have been established in the curriculum over the past several years with high student demand and interest. Given ...From:Albert KauschViews:0 0ratingsTime:01:05:12More inScience Technology

Read the original here:
1. Introduction and Overview- Biotechnology: Panacea or Pandora's Box NQ - Video

Stephen Quake, 2012 Lemelson-MIT Prize Winner
Dr. Stephen Quake, one of the world #39;s most prolific inventors, was recipient of the 2012 $500000 Lemelson-MIT Prize. An adventurer at heart, Quake relishes in the adrenaline that comes from mountain biking and ski mountaineering. It is that same rush he gets from exploring the unknown that drives him to consistently push scientific limits. Quake was recognized for his revolutionary work in drug discovery, genome analysis and personalized medicine.From:LemelsonMITProgramViews:1 0ratingsTime:04:37More inNonprofits Activism

See the original post here:
Stephen Quake, 2012 Lemelson-MIT Prize Winner - Video

Kevin Krenitsky - How does a consumer find out about Foundation Medicine?
Kevin Krenitsky, Chief Operating Officer of Foundation Medicine sits down with Slone Partners at the Personalized Medicine Conference in Boston to discuss Foundation Medicine and their first clinical product, FoundationOne (www.foundationone.com). FoundationOne was released this year at ASCO (http and has since gained significant adoption in the industry. The 8th Annual Personalized Medicine Conference was hosted at Harvard Medical School by Partners Healthcare.From:SlonePartnersMediaViews:11 0ratingsTime:02:45More inScience Technology

See the original post here:
Kevin Krenitsky - How does a consumer find out about Foundation Medicine? - Video

Kevin Krenitsky - Tell us about Foundation Medicine
Kevin Krenitsky, Chief Operating Officer of Foundation Medicine sits down with Slone Partners at the Personalized Medicine Conference in Boston to discuss Foundation Medicine and their first clinical product, FoundationOne (www.foundationone.com). FoundationOne was released this year at ASCO (http and has since gained significant adoption in the industry. The 8th Annual Personalized Medicine Conference was hosted at Harvard Medical School by Partners Healthcare.From:SlonePartnersMediaViews:9 0ratingsTime:03:34More inScience Technology

Excerpt from:
Kevin Krenitsky - Tell us about Foundation Medicine - Video

Personalized Medicine with Dr. Liggett
The University of Florida now has a new research doctor on its campus, Dr. Stephen Liggett. His research focuses on using "personalized medicine" to diagnose and treat patients. It is a process that takes an individual #39;s genetic makeup to create a personalized healing process for a given disease. I reported on, wrote, and edited this story. This story was for CTTV #39;s Spotlight Tampa.From:Caroline MetellViews:1 0ratingsTime:03:50More inNews Politics

Read the original here:
Personalized Medicine with Dr. Liggett - Video